At least three people have died and 65 others have suffered vision issues stemming from contaminated eye drops.
The Centers for Disease Control and Prevention, in partnership with the Food and Drug Administration, said the issues were linked to drops for artificial tears. The people impacted by the contamination reported that they used at least 10 different brands of eye drops with EzriCare Artificial Tears being the most common.
Apotex and Pharmedica were among the brands added to the recall list.
Some notable symptoms of an eye infection include yellow, green or clear discharge from the eyes, pain or discomfort, blurry vision, red eye and increased sensitivity to light.
Last month, the FDA said Global Pharma healthcare, the India-based company that manufactures EzriCare products, did not adequately test for microbial bacteria and also failed to use proper tamper-proof packaging, which ultimately led to the unchecked outbreak.
The Food and Drug Administration is expected to approve the first CRISPR gene-editing therapy.
A new study examines the prevalence of high blood pressure among couples.
A study out of Japan found that a little bit of wasabi can improve memory.
A new study reveals that 3D eye scans can reveal important clues about your kidney health.
Weightless Full Body Workout Routine
Eli Lilly launched Zepbound, the latest product to join the exploding market for weight loss medications.
A new storage drive is using DNA to store data for 100 and 50 years.
Rescuers searching the hazardous slopes of Indonesia’s Mount Marapi volcano found more bodies among the climbers caught by a surprise eruption two days ago, raising the number of confirmed and presumed dead to 23.
Flu is picking up steam while RSV lung infections that can hit kids and older people hard may be peaking, U.S. health officials said.
The maker of Ozempic is suing two pharmacies in Florida for allegedly selling impure versions of the popular weight loss and diabetes management drugs.
